EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study

Yue Lang, Hui Zhang, Rui Feng, Yongzhong Lin

PeerJ · 2026

DOI: 10.7717/peerj.21670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2026. Verfasst von Yue Lang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Parkinson Disease, Metabolomics, Inflammation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease (PD) is a complex neurodegenerative disorder characterized by multifaceted molecular dysregulation. Integrating genetic approaches with metabolomics may help to systematically investigate potential links between metabolites, inflammatory proteins, and PD risk.

Methods

In this pilot discovery phase, untargeted Liquid Chromatography-Mass Spectrometry (LC-MS) was conducted in a small cohort (15 PD patients and 10 healthy controls). Differentially expressed metabolites (DEMs) were identified using variable importance in projection (VIP) > 1, |log 2 FC| ≥ 1, and false discovery rate (FDR)-adjusted q -values < 0.05 (Benjamini–Hochberg method), representing the metabolites remaining significant after multiple-testing correction applied directly at the metabolite discovery stage. Prioritized metabolites were selected by Random Forest, Least absolute shrinkage and selection operator (LASSO) regression, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment. Two-sample Mendelian randomization (MR) was performed using PD Genome-Wide Association Study (GWAS) data from FinnGen R12 (European ancestry: 5,861 cases, 494,487 controls) to evaluate putative causal associations, with FDR correction applied separately within the metabolite and inflammatory protein exposure sets. Mediation MR was used to explore potential mediating roles of 91 circulating inflammatory proteins.

Results

A total of 3,537 metabolites were identified, of which 570 were classified as DEMs, representing the features remaining significant after multiple-testing correction. Integration of Random Forest and LASSO identified 3-phenylpropionylglycine as a key candidate metabolite. KEGG analysis highlighted caffeine metabolism as the top enriched pathway. After FDR correction, MR analyses suggested inverse associations between genetically predicted levels of 3-phenylpropionylglycine ( P FDR = 0.0077, OR = 0.82) and 7-methylxanthine ( P FDR = 0.0349, OR = 0.83) and PD risk. Mediation analysis further indicated that SULT1A1 may partially mediate the association between 3-phenylpropionylglycine and PD.

Conclusion

This exploratory study integrates pilot-scale metabolomics with genetic analyses to identify candidate metabolic signals and inflammatory pathways linked to PD. However, given the small metabolomics sample size, cross-cohort data integration, and potential biological mismatch between plasma-derived metabolites and genetically predicted metabolite levels, these findings should be considered hypothesis-generating and interpreted with caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMetabolomicsInflammationHumansMendelian Randomization AnalysisPilot ProjectsGenome-Wide Association StudyMaleFemaleMiddle AgedAgedChromatography, LiquidCase-Control StudiesMass Spectrometry

Stichwörter der Autor:innen

Caffeine metabolismInflammatory cytokinesMediation analysisMendelian randomizationMetabolomicsParkinson’s disease

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.

Zitieren

APA

Lang, Y., Zhang, H., Feng, R., & Lin, Y. (2026). Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study. PeerJ. https://doi.org/10.7717/peerj.21670

Vancouver

Lang Y, Zhang H, Feng R, Lin Y. Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study. PeerJ. 2026. doi:10.7717/peerj.21670

BibTeX
@article{Lang2026,
  author = {Lang, Yue and Zhang, Hui and Feng, Rui and Lin, Yongzhong},
  title = {Exploring metabolic candidates and inflammatory mediation in Parkinson’s disease: a pilot integrative metabolomics and Mendelian randomization study},
  journal = {PeerJ},
  year = {2026},
  doi = {10.7717/peerj.21670}
}
Kostenlos starten →